Walleye Capital’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.24M Buy
+5,900
New +$1.18M ﹤0.01% 3260

Other funds holding IBB

Walleye Capital's IBB Position: Q3 2026 in Review

Walleye Capital increased its iShares Biotechnology ETF (IBB) stake by 1,395% in Q3 2026, buying an estimated $8.96M and bringing the position to 47,879 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #1264.

Walleye Capital first reported a position in IBB in Q4 2023 and has held it in 10 quarters since. 1,024 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Walleye Capital held 47,879 shares of iShares Biotechnology ETF worth $10.1M as of Q3 2026.
  • Walleye Capital bought 44,677 iShares Biotechnology ETF shares in Q3 2026, an estimated $8.96M.
  • iShares Biotechnology ETF made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1264 holding.
  • Walleye Capital first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 10 quarters since.
  • 1,024 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.